Skip to main content
. 2019 Jun 6;33:91. doi: 10.11604/pamj.2019.33.91.17000

Table 3.

Intradialytic hypotensive and hypertensive changes with clinical and biochemical parameters

Variables Hypotension N = 20, SD±, (%) Hypertension N = 29, SD±, (%) p- value
Age (years) 47.25±15.91 45.89±14.94 0.766
Weight (kg) 69.26±14.46 72.74±13.16 0.396
Sodium (mmol/l) 128.70±10.17 132.20±9.05 0.223
Creatinine (µmol/l) 836.79±347.16 840.68±493.41 0.974
PCV (%) 22.15±3.59 22.21±3.93 0.953
eGFR (mls/min) 11.22±6.43 11.93±5.59 0.690
BFR (mls/min) 275.00±75.22 303.45±66.72 0.661
UF Goal (litres) 2.70±0.88 2.76±0.96 0.826
Dialysis Duration (hrs) 3.58±0.59 3.83±0.36 0.099
No. of Sessions 8.50±13.16 9.48±8.16 0.769
PreDSPB (mmHg) 168.20±27.96 155.14±28.20 0.117
PreDDPB (mmHg) 94.20±12.62 91.10±16.88 0.466
PreDMAP (mmHg) 118.86±13.18 113.02±19.04 0.211
PostDSBP (mmHg) 135.40±32.09 181.97±28.52 0.0001
PostDDBP (mmHg) 74.35±15.96 100.27±16.00 0.0001
PostDMAP (mmHg) 95.03±18.99 127.51±18.17 0.0001
No of Antihypertensives 2.05±0.51 4.62±0.56 0.0001
Diagnosis 0.707
Hypertensive Nephropathy 4(20.0%) 9(31.0%)
Diabetic Nephropathy 5(25.0%) 6(20.7%)
Chronic GN 4(20.0%) 6(20.7%)
Obstructive Uropathy 4(20.0%) 4(13.8%)
Sickle cell Nephropathy 0(0.0%) 1(3.4%)
Toxic Nephropathy 3(15.0%) 2(6.9%)
PKD 0(0.0%) 1(3.4%)

PCV: Packed cell volume, eGFR: Estimated glomerular filtration rate, BFR: Blood flow rate, UF: Ultrafiltration, PreDSBP: Predialysis systolic blood pressure, PreDDBP: Predialysis diastolic blood pressure, PreDMAP: Predialysis mean arterial pressure, PostDSBP: Postdialysis systolic blood pressure, PostDDBP: Postdialysis diastolic blood pressure, PostDMAP: Postdialysisi mean arterial pressure